ArticleBMC public health2025
Social determinants of health and mortality on hyperuricemia adults in the USA from 2007 to 2016: a national cohort study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Social Determinants of Health and Risk of Mortality in Adults with Gout or Hyperuricemia: Insights from the 1999-2018 NHANES.Balkan medical journal · 2026Article
- Association between the triglyceride-glucose index and hyperuricemia in an apparently healthy population with zero metabolic syndrome components: a cross-sectional study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHyperuricemia is associated with higher all-cause and cardiovascular mortality. However, the role of social determinants of health (SDoH) in this context remains unclear. This study aims to examine the relationship between SDoH, hyperuricemia, all-cause and cardiovascular mortality, and explore the mediating role of SDoH in these relationships.
methodsThis cohort study analyzed data from 23,919 US adults (aged ≥ 20) in the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2016, with linked mortality data through December 31, 2019. Two primary exposures were examined: hyperuricemia, defined as serum uric acid level > 420 µmol/L in males and > 360 µmol/L in females, and SDoH, which encompassed education level, marital status, income-to-poverty ratio (PIR), food security, health insurance, regular health-care access, housing instability, and employment. The primary outcomes were all-cause and cardiovascular mortality. Statistical methods included logistic regression, Cox proportional hazard model, and mediation analysis.
resultsThe study cohort had a mean (SD) age of 49.27 (17.63) years, with 48.28% (95%Cl, 47.69%-48.86%) being male, and 68.52% (95%Cl, 65.27%-71.60%) identified as non-Hispanic White. Having three or more unfavorable SDoH significantly mediated the link between hyperuricemia and both all-cause and cardiovascular mortality. SDoH ≥ 6, SDoH = 5, SDoH = 4, and SDoH = 3 mediated 20.30% (P = 0.004), 13.94% (P = 0.044), 23.59% (P = 0.018), and 13.88% (P = 0.008) of the association between hyperuricemia and all-cause mortality, respectively. SDoH ≥ 6, SDoH = 5, SDoH = 4, and SDoH = 3 mediated 15.35% (P = 0.006), 14.87% (P = 0.050), 20.68% (P = 0.026), and 9.45% (P = 0.012) of the association between hyperuricemia and cardiovascular mortality.
conclusionsSDoH significantly mediated the relationship between hyperuricemia and both all-cause and cardiovascular mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.